Overview

Role of Exenatide in Type 1 Diabetes

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if giving exenatide and insulin before a meal would lower blood sugars after the meal. This study may help in developing new treatments to help control high blood sugars after meals. This may help improve overall blood sugar control and prevent the long-term effects of diabetes.
Phase:
Phase 2
Details
Lead Sponsor:
Baylor College of Medicine
Montefiore Medical Center
Collaborator:
National Institutes of Health (NIH)
Treatments:
Exenatide